Notably, triple-negative breast cancer has relatively low levels of ABAT transcripts and protein, and a very poor patient prognosis [35], with overexpression of ABAT reducing migration and invasiveness in triple-negative cell lines [39]. This evidence concerns the gene ABAT and triple-negative breast carcinoma.